HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shaolin Zhang Selected Research

2,2-dichloroacetophenone

11/2017Pharmacological synergism of 2,2-dichloroacetophenone and EGFR-TKi to overcome TKi-induced resistance in NSCLC cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shaolin Zhang Research Topics

Disease

3Hydrocephalus (Hydrocephaly)
06/2013 - 12/2012
1Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
01/2018
1Neoplasms (Cancer)
11/2017
1Gliosis
12/2012

Drug/Important Bio-Agent (IBA)

2KaolinIBA
06/2013 - 06/2013
1CholesterolIBA
01/2018
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2018
1SterolsIBA
01/2018
1Gefitinib (Iressa)FDA Link
11/2017
12,2-dichloroacetophenoneIBA
11/2017
1Procollagen Type IIBA
06/2013
1Collagen Type III (Type III Collagen)IBA
06/2013
1Laminin (Merosin)IBA
06/2013
1Hyaluronic Acid (Hyaluronan)IBA
06/2013
1salicylhydroxamic acid (SHAM)IBA
06/2013
1procollagen Type III-N-terminal peptide (PIIP)IBA
06/2013
1procollagen type I carboxy terminal peptide (PICP)IBA
06/2013
1Minocycline (Cyclops)FDA LinkGeneric
12/2012
1Anti-Bacterial Agents (Antibiotics)IBA
12/2012

Therapy/Procedure

1Therapeutics
11/2017
1Injections
06/2013